Glenmede Trust’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,811
| Closed | -$379K | – | 1295 |
|
|
2022
Q3 | $379K | Buy |
+5,811
| New | +$379K | ﹤0.01% | 884 |
|
|
2022
Q2 | – | Sell |
-3,966
| Closed | -$248K | – | 1307 |
|
|
2022
Q1 | $248K | Buy |
+3,966
| New | +$248K | ﹤0.01% | 1083 |
|
|
2021
Q4 | – | Sell |
-2,441
| Closed | -$272K | – | 1335 |
|
|
2021
Q3 | $272K | Hold |
2,441
| – | – | ﹤0.01% | 1054 |
|
|
2021
Q2 | $394K | Sell |
2,441
-22
| -0.9% | -$3.55K | ﹤0.01% | 950 |
|
|
2021
Q1 | $299K | Buy |
2,463
+7
| +0.3% | +$850 | ﹤0.01% | 973 |
|
|
2020
Q4 | $375K | Buy |
2,456
+936
| +62% | +$143K | ﹤0.01% | 912 |
|
|
2020
Q3 | $126K | Sell |
1,520
-1,800
| -54% | -$149K | ﹤0.01% | 1111 |
|
|
2020
Q2 | $243K | Buy |
3,320
+770
| +30% | +$56.4K | ﹤0.01% | 964 |
|
|
2020
Q1 | $154K | Hold |
2,550
| – | – | ﹤0.01% | 1284 |
|
|
2019
Q4 | $154K | Sell |
2,550
-350
| -12% | -$21.1K | ﹤0.01% | 1284 |
|
|
2019
Q3 | $118 | Sell |
2,900
-3,110
| -52% | -$127 | ﹤0.01% | 1347 |
|
|
2019
Q2 | $282 | Buy |
6,010
+4,210
| +234% | +$198 | ﹤0.01% | 1062 |
|
|
2019
Q1 | $64 | Hold |
1,800
| – | – | ﹤0.01% | 1572 |
|
|
2018
Q4 | $51 | Buy |
+1,800
| New | +$51 | ﹤0.01% | 1578 |
|
|
2018
Q3 | – | Sell |
-2,349
| Closed | -$138K | – | 1522 |
|
|
2018
Q2 | $138K | Buy |
+2,349
| New | +$138K | ﹤0.01% | 1168 |
|